Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Appointment of new Artemis CEO lends weight to sale rumours

The CEO of Artemis Group, Germany's second largest ophthalmology chain by revenue, is stepping down from his position as CEO next week to be replaced by the former MD of German rehabilitation specialist Median Kliniken, who is also an ex McKinsey & Company consultant and investment house managing director. A source tells us this is being done in anticipation of a sale.
January 21, 2021

Muted electronic patient record rollout in Germany

Just 2% of publicly insured Germans have registered to see their electronic patient record (ePA) since access was made mandatory at the beginning of the year. Many either don't know it exists or are worried about data privacy, HBI hears. That settles some answers to the question of whether it's worthwhile giving patients access to their own data.
January 21, 2021

Korian enters long-term real estate partnership

France-based pan-European Care group Korian has entered into a 15-year-partnership with BNP Paribas Cardif and EDF Invest, creating a real estate vehicle with Korian at the helm.
January 14, 2021

Waterland buys Priory, plans €2bn Median merger after propco sale

PE firm Waterland is buying UK mental health and adult specialist care operator The Priory Group from American Acadia Healthcare for €1.2bn and will merge it with existing portfolio company German rehab chain Median to create a c.€2bn revenue group, the sixth-largest for-profit acute operator in Europe by revenue. We talk to Waterland partner Dr Carsten Rahlfs and Median CEO Dr Andre Schmidt on the deal, plans with Priory and whether selling off the majority of its real estate to MPT is sensible.
January 7, 2021

Fresenius Helios buys Eugin, Elsan buys C2S

German and Spanish for-profit hospital operator Fresenius Helios has acquired global IVF operator Eugin from in-administration NMC Health, while French number two hospital group Elsan has bought smaller competitor C2S. What does the deal pricing for both say about relative valuations in the two sectors and any COVID impact? 
December 22, 2020

HBI 2020: Lessons on reaching the patient

An insurer, an integrated healthcare provider and a telehealth player are three providers with very different experiences of being able to reach the patient. HBI looks at four tangible lessons from Aetna, Medicover and Kry from HBI 2020.
December 22, 2020

HBI 2020: Non-COVID lab volumes recover in Q3 but M&A model may be redundant

Non-COVID lab volumes reached their pre-pandemic levels in Q3. But does the pandemic signal the end of the sector's reliance on M&A, and what are the implications of new B2C markets? Operators Unilabs, amedes, Medicover and Dr Lal Pathlabs, B2C platform Daslab and supplier Abbott discussed all this and more at HBI 2020's 'Diagnostics: Opportunities and Challenges' & 'A new global consumer market?' sessions.
December 21, 2020

HBI 2020: The future of domiciliary homecare – meeting an insatiable demand

In many markets there is a growing, perhaps even an insatiable demand for unskilled homecare. Is it a sector where it is possible to make money, and how? Is reimbursement sufficient? How do you attract and retain staff? And what effect is COVID having on the market? An expert panel at HBI 2020 considered all this, together with the biggest risks, and best opportunities, as we all dare to look forward to a more normal life in 2021.
December 21, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us